CECO Q3: Sales Double to $404M, Yet GAAP Loss and Material Weaknesses Linger
CECO sits 43% above its 52-week low of $37.15 on elevated volume (3.7× avg).
Summary
CECO's Q3 revenue doubled to $404.4 million with 41% organic growth and non-GAAP operating income of $55.7 million, but Thermon purchase-accounting charges drove a $2.0 million GAAP loss and debt jumped to $599.3 million. Material weaknesses in internal controls remain unremediated.
Key Events · Earnings and Guidance · CECO
-
Q3 Sales Double on Power Demand
Net sales rose 104.7% to $404.4 million from $197.6 million, including 41% organic growth led by natural gas power generation projects; nine-month sales were $895.3 million, up 60.0%.
-
GAAP Loss Despite Non-GAAP Strength
Q3 GAAP net loss attributable to CECO was $2.0 million (-$0.03 per diluted share) versus $1.5 million of income a year earlier, while non-GAAP operating income reached $55.7 million (13.8% margin) from $17.5 million (8.9%).
-
Thermon Accounting Charges Weigh
Thermon contributed $148.5 million of Q3 revenue and a $28.6 million net loss, including $16.7 million of inventory fair-value step-up in the quarter ($26.2 million year-to-date); total consideration transferred was $2,264.1 million with $1,214.5 million allocated to goodwill.
-
Debt Jumps to Fund the Deal
Total borrowings rose to $599.3 million from $212.4 million at December 31, 2025, including $235.0 million drawn on the Term A-1 facility; unused credit availability was $344.3 million and the company was in compliance with all covenants.
Analysis · CECO · Technology
Revenue doubled to $404.4 million on 41% organic growth, and non-GAAP operating income nearly tripled to $55.7 million. Even so, the quarter still produced a $2.0 million GAAP loss because Thermon purchase accounting is running through the P&L: $16.7 million of inventory step-up in Q3 and $26.2 million year-to-date, plus $68.2 million of acquisition and integration expense over nine months. The balance sheet changed shape with the deal. Total debt is $599.3 million versus $212.4 million at year-end, and goodwill plus intangibles now make up roughly two-thirds of the $3.7 billion asset base, so future impairment testing matters more than it did. Layered on top, management again concluded disclosure controls were not effective at September 30, 2026 because of unremediated material weaknesses at Verantis and in balance-sheet reconciliation work — a governance overhang that persists a year after the first flag.
How filings like this one have moved
In the 30 days to Nov 9, 2026, 47.1% of the 1533 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CECO was trading at $53.04 on NYSE in the Technology sector, with a market capitalization of approximately $3.1B. The 52-week trading range was $37.15 to $101.24. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.